{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:02:30Z","timestamp":1787029350160,"version":"build-2736575974"},"reference-count":73,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Mental health awareness is rising; thus, neurological and psychiatric side effects also benefit from increased attention from the medical and scientific community. Ibuprofen is a well-known non-steroidal anti-inflammatory drug (NSAID) that is often available over-the counter (OTC) for both adults and children, expressing good efficacy in reducing pain and fever through non-selective cyclooxygenase inhibition. As ibuprofen has already been associated with different neuropsychiatric disorders, the aim of this study was to perform an up-to-date analysis of such signals detected in the cases reported in EudraVigilance (EV). Methods: The disproportionality analysis offered a contextual insight into the real-world situation depicted in the analyzed database. Results: From the total cases reported for ibuprofen (n = 58,911), 13.9% contained nervous system disorders (n = 8214) and 10.7% entailed psychiatric disorders (n = 6295). The cases were distributed between all age groups, with a sensible higher incidence in teenagers and in women in general. Severe cases, including deaths, have been reported. By comparison with ketoprofen, acetylsalicylic acid, and diclofenac, ibuprofen presented a higher probability of reporting psychiatric and behavioral symptoms. Regarding cognitive and attention disorders and disturbances, no disproportionate signal was observed between ibuprofen and all other NSAIDs. Sleep disturbances (hypersomnia, narcolepsy and sleep paralysis) are reported as more probable for ibuprofen than for acetylsalicylic acid, naproxen, and diclofenac. A higher risk of reporting suicidal and self-injurious behaviors was noted for ibuprofen versus all other selected NSAIDs. A limitation of the study can be noted as due to suspected causality, not an established one, and EV reports cannot accurately determine adverse drug reaction frequencies. Conclusions: Considering that ibuprofen is easily accessible as an OTC drug and the higher probability of reporting several neuropsychiatric adverse effects as shown by this study, patient counseling, when possible, and general education for the public are valuable tools in managing these adverse reactions.<\/jats:p>","DOI":"10.3390\/ph18091301","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:18:15Z","timestamp":1756484295000},"page":"1301","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacovigilance Insights into Ibuprofen\u2019s Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports"],"prefix":"10.3390","volume":"18","author":[{"given":"Cristina Anamaria","family":"Buciuman","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-1750","authenticated-orcid":false,"given":"Carmen Maximiliana","family":"Dobrea","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1540-641X","authenticated-orcid":false,"given":"Anca","family":"Butuca","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-0430","authenticated-orcid":false,"given":"Adina","family":"Frum","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3167-9864","authenticated-orcid":false,"given":"Felicia Gabriela","family":"Gligor","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai O.","family":"Botea","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5328-333X","authenticated-orcid":false,"given":"Laura Gra\u021biela","family":"Vica\u0219","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania"},{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Eugenia","family":"Mure\u0219an","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6672-1535","authenticated-orcid":false,"given":"Octavia","family":"Gligor","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Maghiar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3410-3870","authenticated-orcid":false,"given":"Alexia","family":"Manole","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-8729","authenticated-orcid":false,"given":"Claudiu","family":"Morgovan","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12325-019-01144-9","article-title":"Ibuprofen Safety at the Golden Anniversary: Are All NSAIDs the Same? A Narrative Review","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ijcp.12055","article-title":"Ibuprofen: From Invention to an OTC Therapeutic Mainstay","volume":"67","author":"Rainsford","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.joca.2015.10.006","article-title":"Cost-Effectiveness of Nonsteroidal Anti-Inflammatory Drugs and Opioids in the Treatment of Knee Osteoarthritis in Older Patients with Multiple Comorbidities","volume":"24","author":"Katz","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2022398","DOI":"10.1001\/jamanetworkopen.2020.22398","article-title":"Comparison of Acetaminophen (Paracetamol) with Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-Analysis","volume":"3","author":"Tan","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/bmjpo-2022-001635","article-title":"Access to Medicines for Children in China","volume":"6","author":"Chen","year":"2022","journal-title":"BMJ Paediatr. Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2013.08.013","article-title":"Faster, Higher, Stronger? Evidence for Formulation and Efficacy for Ibuprofen in Acute Pain","volume":"155","author":"Moore","year":"2014","journal-title":"Pain"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Agboola, A.A., Nowak, A., Duchnik, W., Kucharski, \u0141., Story, A., Story, G., Struk, \u0141., Antosik, A.K., and Ossowicz-Rupniewska, P. (2023). Emulsion-Based Gel Loaded with Ibuprofen and Its Derivatives. Gels, 9.","DOI":"10.3390\/gels9050391"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/a-1577-2955","article-title":"Rectal Administration of Ibuprofen: Comparison of Enema and Suppository Form","volume":"72","author":"Prasaja","year":"2022","journal-title":"Drug Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/JPR.S6993","article-title":"Intravenous Ibuprofen: The First Injectable Product for the Treatment of Pain and Fever","volume":"3","author":"Bookstaver","year":"2010","journal-title":"J. Pain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"29147","DOI":"10.1021\/acsomega.0c03878","article-title":"Recovery of Active Pharmaceutical Ingredients from Unused Solid Dosage-Form Drugs","volume":"5","author":"Pratama","year":"2020","journal-title":"ACS Omega"},{"key":"ref_11","first-page":"443","article-title":"Ibuprofen","volume":"5","author":"Young","year":"2024","journal-title":"Encycl. Toxicol. Fourth Ed."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/0003134820952834","article-title":"Are NSAIDs Safe? Assessing the Risk-Benefit Profile of Nonsteroidal Anti-Inflammatory Drug Use in Postoperative Pain Management","volume":"87","author":"Chang","year":"2021","journal-title":"Am. Surg."},{"key":"ref_13","first-page":"16","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/rheumatology\/kew036","article-title":"Use of Non-Steroidal Anti-Inflammatory Drugs Correlates with the Risk of Venous Thromboembolism in Knee Osteoarthritis Patients: A UK Population-Based Case-Control Study","volume":"55","author":"Lee","year":"2016","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/eurheartj\/ehx508","article-title":"Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients with Arthritis: The PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial","volume":"38","author":"Ruschitzka","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of Acute Myocardial Infarction with NSAIDs in Real World Use: Bayesian Meta-Analysis of Individual Patient Data","volume":"357","author":"Bally","year":"2017","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/apt.15645","article-title":"Systematic Review: Ibuprofen-Induced Liver Injury","volume":"51","author":"Zoubek","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and Practical Approach to the Diagnosis and Management of Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shao, Q.H., Yin, X.D., Liu, H.X., Zhao, B., Huang, J.Q., and Li, Z.L. (2021). Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.750108"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12991-021-00348-0","article-title":"Impact of Adverse Reactions to First-Generation Antipsychotics on Treatment Adherence in Outpatients with Schizophrenia: A Cross-Sectional Study","volume":"20","author":"Bahta","year":"2021","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1590\/1984-0462\/;2019;37;3;00016","article-title":"Ibuprofen-Induced Aseptic Meningitis: A Case Report","volume":"37","author":"Lemos","year":"2019","journal-title":"Rev. Paul. De Pediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"03000605221126660","DOI":"10.1177\/03000605221126660","article-title":"Transient Tunnel Vision and Altered Consciousness after a Single Dose of Ibuprofen","volume":"50","author":"Finsterer","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/B978-0-7020-4086-3.00038-2","article-title":"Nonsteroidal Anti-Inflammatory Drugs Exposure and the Central Nervous System","volume":"119","author":"Auriel","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0031-9384(94)90388-3","article-title":"Nonsteroidal Anti-Inflammatory Drugs Affect Normal Sleep Patterns in Humans","volume":"55","author":"Murphy","year":"1994","journal-title":"Physiol. Behav."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2190\/1B32-79EA-B6H5-395V","article-title":"Nonsteroidal Anti-Inflammatory Drugs and Severe Psychiatric Side Effects","volume":"26","author":"Browning","year":"1996","journal-title":"Int. J. Psychiatry Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1586\/ecp.10.120","article-title":"Defining the COX Inhibitor Selectivity of NSAIDs: Implications for Understanding Toxicity","volume":"3","author":"Knights","year":"2010","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_27","unstructured":"Saad, J., and Pellegrini, M.V. (2023). Nonsteroidal Anti-Inflammatory Drugs Toxicity, StatPearls."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2165\/00002018-199207060-00006","article-title":"Neuropsychiatric Reactions to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): The New Zealand Experience","volume":"7","author":"Clark","year":"1992","journal-title":"Drug Saf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archinte.1991.00400070083009","article-title":"Central Nervous System Side Effects of Nonsteroidal Anti-Inflammatory Drugs: Aseptic Meningitis, Psychosis, and Cognitive Dysfunction","volume":"151","author":"Hoppmann","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","article-title":"Ibuprofen: Pharmacology, Efficacy and Safety","volume":"17","author":"Rainsford","year":"2009","journal-title":"Inflammopharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20420986221125010","DOI":"10.1177\/20420986221125006","article-title":"Pharmacovigilance: Reporting Requirements throughout a Product\u2019s Lifecycle","volume":"13","author":"Lucas","year":"2022","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_32","unstructured":"European Medicines Agency (2021). EudraVigilance\u2014European Database of Suspected Adverse Drug Reaction Reports, European Medicines Agency."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Coca, J.R., Coca-Asensio, R., and Esteban Bueno, G. (2022). Socio-Historical Analysis of the Social Importance of Pharmacovigilance. Front. Sociol., 7.","DOI":"10.3389\/fsoc.2022.974090"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2417399","DOI":"10.1080\/20523211.2024.2417399","article-title":"Pharmacovigilance: The Evolution of Drug Safety Monitoring","volume":"17","author":"Khan","year":"2024","journal-title":"J. Pharm. Policy Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.12688\/f1000research.21402.1","article-title":"Pharmacovigilance in Perspective: Drug Withdrawals, Data Mining and Policy Implications","volume":"8","author":"Alomar","year":"2019","journal-title":"F1000Research"},{"key":"ref_36","unstructured":"(2025, July 20). Serious Adverse Reaction|European Medicines Agency (EMA). Available online: https:\/\/www.ema.europa.eu\/en\/glossary-terms\/serious-adverse-reaction."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/EJA.0000000000001088","article-title":"Improving Perisurgical Pain Control: Ten Mistakes to Be Avoided","volume":"37","author":"Botea","year":"2020","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.2042-7158.2011.01340.x","article-title":"Pain, Analgesia and Genetics","volume":"63","author":"Muralidharan","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_39","first-page":"e43960","article-title":"Epigenetics in Neurological and Psychiatric Disorders: A Comprehensive Review of Current Understanding and Future Perspectives","volume":"15","author":"Grezenko","year":"2023","journal-title":"Cureus"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2165\/00003495-200464230-00001","article-title":"NSAID-Related Psychiatric Adverse Events: Who Is at Risk?","volume":"64","author":"Onder","year":"2004","journal-title":"Drugs"},{"key":"ref_41","first-page":"836","article-title":"Effect of Ibuprofen on BrainAGE: A Randomized, Placebo-Controlled, Dose-Response Exploratory Study","volume":"3","author":"Le","year":"2018","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12325-019-01201-3","article-title":"Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature","volume":"37","author":"Farkouh","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Roals\u00f8, E.S., Klonteig, S., Kraft, B., Skarstein, S., Aalberg, M., and Jonassen, R. (2024). Associations between Over-the-Counter Analgesics Usage and Symptoms of Anxiety and Depression in Adolescents: A Network Analysis. BMC Psychiatry, 24.","DOI":"10.1186\/s12888-024-05802-3"},{"key":"ref_44","unstructured":"Fischer, M.A., and Jan, A. (2023). Medication-Overuse Headache, StatPearls."},{"key":"ref_45","unstructured":"(2025, June 18). Stopping the Vicious Cycle of Rebound Headaches\u2014Harvard Health. Available online: https:\/\/www.health.harvard.edu\/blog\/stopping-the-vicious-cycle-of-rebound-headaches-2019110718180."},{"key":"ref_46","first-page":"205","article-title":"Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Reduce Suicidal Ideation and Depression","volume":"28","author":"Lehrer","year":"2019","journal-title":"Discov. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Berk, M., Dean, O., Drexhage, H., McNeil, J.J., Moylan, S., O\u2019Neil, A., Davey, C.G., Sanna, L., and Maes, M. (2013). Aspirin: A Review of Its Neurobiological Properties and Therapeutic Potential for Mental Illness. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-74"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Xie, W.L., Xiang, D.C., Li, Y.Y., Ge, M.L., and Deng, A.P. (2025). An Exploratory Study Evaluating the 20 Medications Most Commonly Associated with Suicidal Ideation and Self-Injurious Behavior in the FAERS Database. BMC Pharmacol. Toxicol., 26.","DOI":"10.1186\/s40360-025-00858-7"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/cc4850","article-title":"Fatality after Deliberate Ingestion of Sustained-Release Ibuprofen: A Case Report","volume":"10","author":"Wood","year":"2006","journal-title":"Crit. Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006565-200002000-00012","article-title":"Central Nervous System Manifestations of an Ibuprofen Overdose Reversed by Naloxone","volume":"16","author":"Easley","year":"2000","journal-title":"Pediatr. Emerg. Care"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0196-0644(86)80617-5","article-title":"Ibuprofen Overdose: 126 Cases","volume":"15","author":"Hall","year":"1986","journal-title":"Ann. Emerg. Med."},{"key":"ref_52","unstructured":"(2025, July 31). Ibuprofen Tablets, USP (400 Mg, 600 Mg and 800 Mg) Rx Only, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=17577b3b-e755-45d1-8b53-775d058578b2&type=display."},{"key":"ref_53","unstructured":"(2025, July 31). PRAC Recommends Updating Advice on Use of High-Dose Ibuprofen|European Medicines Agency (EMA). Available online: https:\/\/www.ema.europa.eu\/en\/news\/prac-recommends-updating-advice-use-high-dose-ibuprofen."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s100670050114","article-title":"Non-Steroidal Anti-Inflammatory Drugs with Adverse Psychiatric Reactions: Five Case Reports","volume":"18","author":"Jiang","year":"1999","journal-title":"Clin. Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e00338","DOI":"10.1002\/brb3.338","article-title":"Inflammation and Depression: Combined Use of Selective Serotonin Reuptake Inhibitors and NSAIDs or Paracetamol and Psychiatric Outcomes","volume":"5","author":"Petersen","year":"2015","journal-title":"Brain Behav."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNF.0000000000000448","article-title":"The Effects of Ibuprofen Consumption on the Incidence of Postpartum Depression","volume":"44","author":"Kapulsky","year":"2021","journal-title":"Clin. Neuropharmacol."},{"key":"ref_57","unstructured":"(2025, June 18). NSAIDS Reduce Risk of Postoperative Delirium\u2014Surgery International. Available online: https:\/\/surgery.international\/nsaids-reduce-risk-of-postoperative-delirium\/."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/JPR.S363110","article-title":"Effectiveness of Intravenous Ibuprofen on Emergence Agitation in Children Undergoing Tonsillectomy with Propofol and Remifentanil Anesthesia: A Randomized Controlled Trial","volume":"15","author":"Gao","year":"2022","journal-title":"J. Pain Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.clinthera.2006.11.018","article-title":"Effects of Ibuprofen on Sleep Quality as Measured Using Polysomnography and Subjective Measures in Healthy Adults","volume":"28","author":"Gengo","year":"2006","journal-title":"Clin. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Koonalintip, P., Phillips, K., and Wakerley, B.R. (2024). Medication-Overuse Headache: Update on Management. Life, 14.","DOI":"10.3390\/life14091146"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2017.02.003","article-title":"Nonsteroidal Anti-Inflammatory Drugs in Clinical and Experimental Epilepsy","volume":"131","author":"Radu","year":"2017","journal-title":"Epilepsy Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Rainsford, K.D. (2015). Ibuprofen in Prevention of Neurodegenerative Diseases. Ibuprofen: Discovery, Development and Therapeutics, Wiley Online Library.","DOI":"10.1002\/9781118743614"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.2723","article-title":"Effects of Non-Steroidal Anti-Inflammatory Drug Treatments on Cognitive Decline Vary by Phase of Pre-Clinical Alzheimer Disease: Findings from the Randomized Controlled Alzheimer\u2019s Disease Anti-Inflammatory Prevention Trial","volume":"27","author":"Leoutsakos","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_64","unstructured":"European Medicines Agency (2025). European Medicines Agency Policy on Access to EudraVigilance Data for Medicinal Products for Human Use (EudraVigilance Access Policy), European Medicines Agency."},{"key":"ref_65","unstructured":"Medicines Agency, European (2017). Guideline on Good Pharmacovigilance Practices (GVP)\u2014Module VI\u2014Collection, Management and Submission of Reports of Suspected Adverse Reactions to Medicinal Products (Rev 2), European Medicines Agency."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Popa Ilie, I.R., Dobrea, C.M., Butuca, A., Homorodean, C., Morgovan, C., Vonica-Tincu, A.L., Gligor, F.G., Ghibu, S., and Frum, A. (2024). Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance. Pharmaceuticals, 17.","DOI":"10.3390\/ph17121631"},{"key":"ref_67","unstructured":"(2025, July 20). English|MedDRA. Available online: https:\/\/www.meddra.org\/how-to-use\/support-documentation\/english\/welcome."},{"key":"ref_68","unstructured":"(2025, July 20). MedDRA Hierarchy|MedDRA. Available online: https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy."},{"key":"ref_69","unstructured":"MedDRA (2021). Introductory Guide MedDRA Version 24.1 Notice to Reader MedDRA Introductory Guide, MedDRA."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"key":"ref_71","unstructured":"(2023, January 02). Screening for Adverse Reactions in EudraVigilance. Available online: www.ema.europa.eu\/contact."},{"key":"ref_72","unstructured":"MedCalc Software Ltd (2025). Odds Ratio Calculator, version 22.001, MedCalc Software Ltd.. Available online: https:\/\/www.medcalc.org\/calc\/odds_ratio.php."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Vonica, R.C., Morgovan, C., Butuca, A., Pumnea, M., Cipaian, R.C., Frum, A., Dobrea, C.M., Vonica-Tincu, A.L., Pacnejer, A.M., and Batar, F. (2025). Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database. Cancers, 17.","DOI":"10.3390\/cancers17040663"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1301\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:38Z","timestamp":1760034938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":73,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ph18091301"],"URL":"https:\/\/doi.org\/10.3390\/ph18091301","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}